Persuading the Prescribers: Pharmaceutical Industry Marketing and its Influence on Physicians and Patients – Pew Charitable Trusts, pharmaceutical industry marketing.#Pharmaceutical #industry #marketing

Posted On Jul 2 2018 by

Persuading the Prescribers: Pharmaceutical Industry Marketing and its Influence on Physicians and Patients In 2012, the pharmaceutical industry spent more than $27 billion on drug promotion 1 more than $24 billion on marketing to physicians and over $3 billion on advertising to consumers (mainly through television commercials). 2 This approach is designed to promote drug companies’ products by influencing doctors’ prescribing practices. 3 2013 The Pew Charitable Trusts Source: Cegedim Strategic Data, 2012 U.S. Pharmaceutical Company Promotion Spending (2013). Detailing: This marketing approach refers to face-to-face promotional activities directed toward physicians and pharmacy directors. Pharmaceutical representatives typically visit doctors to …


MANUFACTURING DOCUMENTATION IN PHARMACEUTICAL INDUSTRY- DEVELOPMENT AND IMPLEMENTATION, PharmaTutor, pharmaceutical industry articles.#Pharmaceutical #industry #articles

Posted On Jun 22 2018 by

MANUFACTURING DOCUMENTATION IN PHARMACEUTICAL INDUSTRY- DEVELOPMENT AND IMPLEMENTATION Krunal Parikh 1* , Mr. Maheshkumar Kataria 2 , Jatin Patel 1 2 Assistant professor, Department of pharmaceutics, 1 Seth G.L. Bihani S.D. College of Technical Education, Institute of Pharmaceutical Sciences and Drug Research, Sri Ganganagar, Rajasthan, INDIA Documentation is an integral part of good manufacturing practices. It defines a system of information and control so that risks so inherent in misinterpretation and/or error in oral communication are minimized. It consequently strengthens the quality, and its consistency, of all goods and services, as those responsible for the specific operations have clear, unambiguous …


Home Page, PhRMA, pharmaceutical industry today.#Pharmaceutical #industry #today

Posted On Jun 20 2018 by

pharmaceutical industry today PhRMA represents the country’s leading biopharmaceutical research companies and supports the search for new treatments and cures. Advocacy From accessing medicines to intellectual property to drug safety, PhRMA is devoted to advancing public policies that support innovative medical research, improve treatments and yield real results. Science Today, cutting-edge medical science is transforming patients’ lives. Discover how scientists and researchers are advancing science. Patients Patient support and assistance is the top priority for PhRMA’s member companies, who are working hard to improve patients’ lives through the discovery and development of new medicines and treatments. Resources Explore the Resource …


Biotech Industry, Biotech News, Biotechnology Articles, biotechnology industry news.#Biotechnology #industry #news

Posted On Jun 20 2018 by

biotechnology industry news Certain microRNAs in the saliva of concussion patients could help gauge the severity of concussions and predict the length of concussion symptoms. Toxicity knocks Ardelyx s hyperkalemia hopes back to preclinic Unexpected side effects have spelled the end for Ardelyx’s drug candidate to treat elevated potassium levels in the blood, which was in phase 3 testing. Cytokinetics cans lead drug after phase 3 ALS wipeout Cytokinetics canned tirasemtiv after it failed to beat placebo against the primary endpoint or any of the secondary goals in an ALS trial. Step Pharma bags cash for CTPS1 autoimmune R D …


SIBC, Sugar Industry Biotech Council, Sugar Beets, Sugar Cane, biotechnology industry news.#Biotechnology #industry #news

Posted On Jun 20 2018 by

Sugar Industry Biotech Council Welcome to the Sugar Industry Biotech Council Sugar is a carbohydrate that occurs naturally in fruits and vegetables. Of all known plants, sugar is most highly concentrated in sugar beets and sugar cane. The sucrose (sugar) from sugar beets and sugar cane is identical, and the same as the sucrose found in fruits and vegetables. Whether from sugar beets or sugar cane, or from sugar crops grown using conventional, biotech or organic methods, sugar is pure and natural and has identical nutritional value, composition and wholesomeness. The sugar is the same no matter its original plant …


Drug Discovery Informatics Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017, pharmaceutical industry market share.#Pharmaceutical #industry #market #share

Posted On Jun 19 2018 by

Drug Discovery Informatics Market Drug discovery is a process that involves generating of a large volume of information and data. Several innovative technologies are used for this data generation. With the use of cloud-based technologies, it is now possible to process, store, and analyze a large volume of data at a low cost. The pathway analysis of drug discovery includes the identification of potential drug targets associated with diseases, applications in biomarker studies, and the study of protein interactions. Various biomarkers in drug discovery are included because biomarkers indicates a change in expression studies, this informatics helps in categorization of …


Persuading the Prescribers: Pharmaceutical Industry Marketing and its Influence on Physicians and Patients – Pew Charitable Trusts, pharmaceutical industry data.#Pharmaceutical #industry #data

Posted On Jun 19 2018 by

Persuading the Prescribers: Pharmaceutical Industry Marketing and its Influence on Physicians and Patients In 2012, the pharmaceutical industry spent more than $27 billion on drug promotion 1 more than $24 billion on marketing to physicians and over $3 billion on advertising to consumers (mainly through television commercials). 2 This approach is designed to promote drug companies’ products by influencing doctors’ prescribing practices. 3 2013 The Pew Charitable Trusts Source: Cegedim Strategic Data, 2012 U.S. Pharmaceutical Company Promotion Spending (2013). Detailing: This marketing approach refers to face-to-face promotional activities directed toward physicians and pharmacy directors. Pharmaceutical representatives typically visit doctors to …


Pharmaceutical Technology, pharmaceutical industry data.#Pharmaceutical #industry #data

Posted On Jun 12 2018 by

pharmaceutical industry data Resistance to antibiotics is rising but the business model for developing new antibiotic drugs is broken. Could CARB-X, the world’s. NICE’s head of scientific advice on pharma R D in a personalised era Pharma Technology Focus – Issue 65 Boehringer Ingelheim’s Fremont Manufacturing Facility Expansion, California Rocking the US generics boat: Indian competition and FDA pressure Cold Spring Harbor Laboratory Center for Therapeutics Research, New York Blockchain in pharma: opportunities in the supply chain Latest News Tesaro’s Zejula receives EC approval to treat ovarian cancer in Europe Study finds gastric treatment lansoprazole may target tuberculosis UK CMA …


Pharmaceutical industry news, articles, jobs, reports, advice and services, pharma industry jobs.#Pharma #industry #jobs

Posted On Jun 8 2018 by

First Herceptin biosimilar cleared in Europe Ontruzant is approved for all the same indications as Roche s blockbuster EMA forges closer ties with HTA umbrella group Agrees joint work plan with the European Network for Health Technology Assessment Novartis’ orphan drug Tasigna wins EU expanded indication The CML medication can now treat paediatric patients Amsterdam picked to host the European Medicines Agency But regulator faces a challenging relocation project to depart from London Concordia accused of overcharging NHS for thyroid drug The pharma firm said to have abused its position within the UK market Sales news Research news The state …


Trump to pharma: You – re – getting away with murder, and I – m the one to stop it, FiercePharma, pharma industry jobs.#Pharma #industry #jobs

Posted On Jun 8 2018 by

Trump to pharma: You re getting away with murder, and I m the one to stop it Remember the Trump euphoria that hit biopharma stocks after the president-elect captured the Electoral College in November? Well, scratch that. At his first press conference since July, Trump said Wednesday that the industry is “getting away with murder”—and the government needs to take action. Trump said the government should require competitive bidding to get drug costs down, claiming that the U.S. can save “billions of dollars” with such a process. He called out pharma lobbyists and their power in Washington. And, repeating a …